<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-02</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-02</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>152</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
å¯Œé›†CD200+ CD8 Tç»†èƒï¼Œé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’ï¼Œæ˜¾è‘—æå‡æŠ—è‚¿ç˜¤å…ç–«ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢ç²¾æ°¨é…¸å‰¥å¤ºå¯¹å…ç–«ç»†èƒåŠŸèƒ½åŠæŠ—è‚¿ç˜¤ä½œç”¨çš„å½±å“ã€‚<br />
- ç ”å‘æ–°å‹åŒæŠ—åŸDNAç–«è‹—ï¼Œè¯±å¯¼é’ˆå¯¹å…ç–«æŠ‘åˆ¶æ€§å£è…”ç™Œçš„å¼ºæ•ˆæŠ—è‚¿ç˜¤å…ç–«ã€‚<br />
- åˆ©ç”¨å¤šç»„å­¦æ•´åˆæ–¹æ³•ï¼ˆè¡¨è§‚é—ä¼ å­¦ã€ç©ºé—´è½¬å½•ç»„å­¦ï¼‰è§£æè„Šç´¢ç˜¤å¾®ç¯å¢ƒã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- ç»“åˆscRNA-seqã€ATAC-seqç­‰æŠ€æœ¯ï¼Œå…¨é¢å‰–æå…ç–«ç»†èƒäºšç¾¤åœ¨è‚¿ç˜¤åŠç–¾ç—…å‘ç”Ÿå‘å±•ä¸­çš„ä½œç”¨ã€‚<br />
- åº”ç”¨ç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯ï¼Œç²¾ç»†ç»˜åˆ¶ç»„ç»‡å†…å…ç–«ç»†èƒåŠ¨æ€åˆ†å¸ƒä¸åŠŸèƒ½ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç§‘å­¦ç•Œé¦–æ¬¡æ­ç¤ºäº†é˜³å…‰å¦‚ä½•å…³é—­çš®è‚¤å†…æºæ€§ç™Œç—‡é˜²å¾¡æœºåˆ¶ï¼Œå¹¶é˜æ˜äº†æœç³–å¦‚ä½•æ‚„ç„¶åŠ å‰§å…ç–«ç»†èƒçš„ç‚ç—‡ååº”ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- é˜æ˜é˜³å…‰æš´éœ²å¯¼è‡´çš®è‚¤ç»†èƒå†…ç‚ç—‡å¤±æ§åŠç™Œç—‡é£é™©å‡é«˜çš„å…·ä½“åˆ†å­æœºåˆ¶ã€‚<br />
- æ­ç¤ºæœç³–å¦‚ä½•é€šè¿‡å¢åŠ å…ç–«ç»†èƒä¸Šçš„ç‚ç—‡å—ä½“ï¼Œæå‡å…¶å¯¹ç»†èŒæ¯’ç´ çš„æ•æ„Ÿæ€§ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å‘ç°é˜³å…‰æ¿€æ´»çš„â€œå¼€å…³â€è°ƒæ§çš®è‚¤ç™Œé˜²å¾¡ã€‚<br />
- è¯†åˆ«æœç³–è¯±å¯¼çš„å…ç–«ç»†èƒè¶…æ•ååº”ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (150æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE311149 CD200+ CD8 T ç»†èƒé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºç”Ÿæˆï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’å¹¶æ”¹å–„æŠ—è‚¿ç˜¤å…ç–«[scRNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€macrophageã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qianlong Kang ; Zedong Jiang ; Keqin Tan ; Xuelei MaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusArginine is indispensable for both tumor progression and the function of immune cells, yet how arginine deprivation within the tumor microenvironment shapes anti-tumor immunity has remained unclear. In this study, we established an in vivo arginine-restriction model using a diet lacking arginine, which significantly suppressed tumor growth and activated global anti-tumor immune responses. Mechanistically, arginine deprivation triggered the integrated stress response in CD8+ T cells via the GCN2â€“cREL signaling axis, leading to elevated CD200 expression. These CD200+ CD8+ T cells in turn enhanced the antigen cross-presentation capacity of tumor-associated macrophages through CD200â€“CD200R interactions, forming a cooperative immune network that reinforced anti-tumor activity. Moreover, this arginine deprivationâ€“induced cellular synergy improved the therapeutic efficacy of immunotherapy in colorectal cancer models. We further conducted a single-arm phase I clinical trial (NCT07038044), which demonstrated that an arginine-free diet is both feasible and safe for modulating systemic immunity in patients. Together, our findings provide a new conceptual framework for understanding the role of arginine in reshaping the tumor immune microenvironment and highlight arginine restriction as a promising and clinically translatable anti-tumor strategy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311149" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE311148 CD200+ CD8 T ç»†èƒé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºç”Ÿæˆï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’å¹¶æ”¹å–„æŠ—è‚¿ç˜¤å…ç–«[RNA-Seq 2]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€macrophageã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qianlong Kang ; Zedong Jiang ; Keqin Tan ; Xuelei MaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusArginine is indispensable for both tumor progression and the function of immune cells, yet how arginine deprivation within the tumor microenvironment shapes anti-tumor immunity has remained unclear. In this study, we established an in vivo arginine-restriction model using a diet lacking arginine, which significantly suppressed tumor growth and activated global anti-tumor immune responses. Mechanistically, arginine deprivation triggered the integrated stress response in CD8+ T cells via the GCN2â€“cREL signaling axis, leading to elevated CD200 expression. These CD200+ CD8+ T cells in turn enhanced the antigen cross-presentation capacity of tumor-associated macrophages through CD200â€“CD200R interactions, forming a cooperative immune network that reinforced anti-tumor activity. Moreover, this arginine deprivationâ€“induced cellular synergy improved the therapeutic efficacy of immunotherapy in colorectal cancer models. We further conducted a single-arm phase I clinical trial (NCT07038044), which demonstrated that an arginine-free diet is both feasible and safe for modulating systemic immunity in patients. Together, our findings provide a new conceptual framework for understanding the role of arginine in reshaping the tumor immune microenvironment and highlight arginine restriction as a promising and clinically translatable anti-tumor strategy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311148" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE311146 CD200+ CD8 T ç»†èƒé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºç”Ÿæˆï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’å¹¶æ”¹å–„æŠ—è‚¿ç˜¤å…ç–«[RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€macrophageã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qianlong Kang ; Zedong Jiang ; Keqin Tan ; Xuelei MaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusArginine is indispensable for both tumor progression and the function of immune cells, yet how arginine deprivation within the tumor microenvironment shapes anti-tumor immunity has remained unclear. In this study, we established an in vivo arginine-restriction model using a diet lacking arginine, which significantly suppressed tumor growth and activated global anti-tumor immune responses. Mechanistically, arginine deprivation triggered the integrated stress response in CD8+ T cells via the GCN2â€“cREL signaling axis, leading to elevated CD200 expression. These CD200+ CD8+ T cells in turn enhanced the antigen cross-presentation capacity of tumor-associated macrophages through CD200â€“CD200R interactions, forming a cooperative immune network that reinforced anti-tumor activity. Moreover, this arginine deprivationâ€“induced cellular synergy improved the therapeutic efficacy of immunotherapy in colorectal cancer models. We further conducted a single-arm phase I clinical trial (NCT07038044), which demonstrated that an arginine-free diet is both feasible and safe for modulating systemic immunity in patients. Together, our findings provide a new conceptual framework for understanding the role of arginine in reshaping the tumor immune microenvironment and highlight arginine restriction as a promising and clinically translatable anti-tumor strategy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311146" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE311145 CD200+ CD8 T ç»†èƒé€šè¿‡ç²¾æ°¨é…¸å‰¥å¤ºç”Ÿæˆï¼Œæ¿€æ´»å·¨å™¬ç»†èƒäº¤å‰å‘ˆé€’å¹¶æ”¹å–„æŠ—è‚¿ç˜¤å…ç–« [ATAC-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€T cellã€macrophageã€ATAC-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Qianlong Kang ; Zedong Jiang ; Keqin Tan ; Xuelei MaSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusArginine is indispensable for both tumor progression and the function of immune cells, yet how arginine deprivation within the tumor microenvironment shapes anti-tumor immunity has remained unclear. In this study, we established an in vivo arginine-restriction model using a diet lacking arginine, which significantly suppressed tumor growth and activated global anti-tumor immune responses. Mechanistically, arginine deprivation triggered the integrated stress response in CD8+ T cells via the GCN2â€“cREL signaling axis, leading to elevated CD200 expression. These CD200+ CD8+ T cells in turn enhanced the antigen cross-presentation capacity of tumor-associated macrophages through CD200â€“CD200R interactions, forming a cooperative immune network that reinforced anti-tumor activity. Moreover, this arginine deprivationâ€“induced cellular synergy improved the therapeutic efficacy of immunotherapy in colorectal cancer models. We further conducted a single-arm phase I clinical trial (NCT07038044), which demonstrated that an arginine-free diet is both feasible and safe for modulating systemic immunity in patients. Together, our findings provide a new conceptual framework for understanding the role of arginine in reshaping the tumor immune microenvironment and highlight arginine restriction as a promising and clinically translatable anti-tumor strategy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311145" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE310571 åŒæŠ—åŸç‹—éª¨DNAç–«è‹—å¯è¯±å¯¼é’ˆå¯¹å…ç–«æŠ‘åˆ¶æ€§å£è…”ç™Œçš„å¼ºæ•ˆæŠ—è‚¿ç˜¤å…ç–«åŠ›</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immunityã€vaccineã€antigen<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Grace Tan ; Natalia Savelyeva ; Chuan Wang ; Martina Meschis ; Christian OttensmeierSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusImmunotherapy has demonstrated durable responses in a subset of patients with head and neck cancer, offering potential survival benefits to those with poor prognoses and resistance to first-line treatments. Despite this, only a modest 15-20% are shown to respond. Cancer vaccines have recently demonstrated efficacy in some solid tumours including melanoma, as well as immune-cold pancreatic and liver cancer, inducing a cytotoxic T cell response and eradicating cancer cells. Our previous research identified cancer testis antigens MAGED4B and FJX1 as highly immunogenic and overexpressed in the majority of HPV-independent head-and-neck squamous cell carcinoma (HPVnegHNSCC) patients. In this study, we developed a novel DNA vaccine utilising the non-plasmid doggyboneTM (dbDNATM) platform to deliver these antigens for targeting head and neck cancer. A series of doggyboneTM vaccine prototypes targeting MAGED4B and FJX1 were generated both to optimise the backbone and to present antigens in an immunogenic form. Vaccine immunogenicity and cytotoxicity were accessed using interferon-gamma. Enzyme-Linked Immunospot (ELISpot) assay. Vaccine efficacy was evaluated in the MOC-2 oral cancer model through tumour monitoring, assessing the infiltration of CD4+, CD8+ and regulatory T cells by immunohistochemistry as well as RNAseq analysis. The optimised dual antigen dbDNA DNA vaccine significantly reduced tumour size. Furthermore, combining the vaccine with anti-PD1 therapy significantly delayed tumour growth and metastasis, thereby enhancing survival in tumour-bearing mice. Vaccination resulted in significant recruitment of CD4+ and CD8+ T cells but not regulatory T cells. IHC analysis also confirmed the ability of dbDNAâ„¢ vaccine TGL-100 OPT in shifting M2 to M1 polarisation, highlighting their therapeutic promise. Transcriptomic analysis of immune cells in the tumour indicates that vaccination promotes long term anti-tumour responses by upregulating memory T cell genes T cell factor-7 (Tcf7) and lymphoid enhancer binding factor 1 (Lef1) while suppressing PDL-1 and inhibiting anti-inflammatory cytokines such as IL-10 and IL-27. These findings suggest that our cancer vaccine effectively recruits cytotoxic T cells to immune cold tumours, minimising the hostâ€™s immune inhibitory mechanisms within...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310571" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE308436 éª¶éª¨è„Šç´¢ç˜¤è¡¨è§‚é—ä¼ å­¦ã€ç©ºé—´è½¬å½•ç»„å­¦å’Œå…ç–«å¾®ç¯å¢ƒçš„å¤šæ¨¡æ€æ•´åˆç ”ç©¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yee H Foong ; George Jour ; Garima Sinha ; Jamal Benhamida ; Nathan Aleynick ; Yanyun Li ; Travis Hollmann ; Mrinal Gounder ; Rohan Sardana ; Carla Saoud ; Max Vaynrub ; Patrick Boland ; Rami Vanguri ; Meera HameedSeries Type : Methylation profiling by genome tiling arrayOrganism : Homo sapiensMultimodal study elucidated the complex epigenetic and immunological landscape in sacral chordomas<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308436" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE310136 ç²¾å‡†çº³ç±³ç–—æ³•é‡å¡‘è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒï¼Œé€†è½¬èƒ°è…ºç™Œä¸­çš„å…ç–«æŠ‘åˆ¶ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€macrophage<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yunching Chen ; Hsin-Mei LeeSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPancreatic ductal adenocarcinoma (PDAC) is characterized by an immunosuppressive stroma rich in tumor-associated macrophages (TAMs) that limit the therapeutic efficacy. We introduce a TAM-targeted nanotherapy platform that selectively delivers either a CSF1R inhibitor or the STING agonist cGAMP to immunosuppressive TAMs. While CSF1R inhibitorâ€“loaded nanoparticles efficiently depleted TAMs and produced moderate antitumor effects, TAM-targeted cGAMP nanoparticles reprogrammed TAMs into immune-stimulating effectors. This reprogramming normalized aberrant vasculature, alleviated desmoplasia, and enhanced infiltration and activation of cytotoxic immune cells. In combination with gemcitabine, PD-1 checkpoint blockade, or CAR-NK cell therapy, TAM-targeted STING activation provided an in situ immunostimulatory signal that markedly improved antitumor efficacy in preclinical PDAC models. Ex vivo efficacy in human PDAC tissues and a favorable safety profile show the translational potential of this TAM-targeted nanotherapy to overcome the immune desert of PDAC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310136" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE306162 SPP1+å·¨å™¬ç»†èƒä¿ƒè¿›æ¥è§¦æ€§è¿‡æ•å¼•èµ·çš„æ¯›å‘ç”Ÿé•¿[ç©ºé—´è½¬å½•ç»„å­¦]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Kai-Rong Huang ; Sabrina Mai-Yi Fan ; Sung-Jan LinSeries Type : OtherOrganism : Mus musculusUsing Visium HD spatial transcriptomics and immunostaining, we mapped skin compartment dynamics during DPCP-induced allergic contact dermatitis. Dermal white adipose tissue transitioned from metabolic homeostasis to immune activation and inflammatory remodeling, accompanied by sustained lipolysis. Concurrently, CD45âº immune cells accumulated in the lower dermis and dWAT. These findings identify dWAT as an immune-metabolic hub orchestrating inflammatory progression and highlight spatial transcriptomics as a powerful tool for dissecting skin niche regulation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306162" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE296929 E2F4/SETD1Aè½´ä»‹å¯¼çš„METTL3ç”²åŸºåŒ–é€šè¿‡æŠ‘åˆ¶å†…æºæ€§é€†è½¬å½•å…ƒä»¶è¡¨è¾¾ä¿ƒè¿›è‚¿ç˜¤å…ç–«é€ƒé€¸</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immuneã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Methylation profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Homo sapiensColorectal cancer (CRC) progression and recurrence persist as major clinical challenges despite standard therapies. Emerging evidence underscores that tumor relapse arises from crosstalk between malignant cells and the immunosuppressive microenvironment, yet the role of non-histone lysine methylation in this interplay remains unclear. Here, we identify di-methylation of lysine 513 (K513) on methyltransferase-like 3 (METTL3) as a key epigenetic modification associated with CRC progression and recurrence. Mechanistically, we reveal that SETD1A catalyzes METTL3 K513 methylation, enhancing its binding affinity to S-adenosylmethionine (SAM) and augmenting RNA mâ¶A deposition. Strikingly, METTL3 methylation suppresses endogenous retroelements expression, leading to impaired type I interferon responses and tumor immune evasion. We further uncover a fluorouracil-induced E2F4/SETD1A/METTL3 regulatory axis, wherein E2F4 self-regulation activates SETD1A to drive METTL3 methylation. Targeting this axis through pharmacological inhibition of E2F4 or genetic disruption of METTL3 methylation synergizes with immune checkpoint blockade (ICB), significantly suppressing tumor growth. Our findings unveil a methylation-dependent regulatory mechanism that reshapes the tumor immune microenvironment, offering a novel therapeutic strategy for CRC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296929" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE276263 Epigenetic insights into fertility: involvement of immune cell methylation in dairy cows reproduction</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€epigeneticã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lotfi Bouzeraa ; Helene Martin ; Clement Plessis ; Pascal Dufour ; Jessica C Marques ; Sydney Moore ; Ronaldo Cerri ; Marc-Andre SirardSeries Type : OtherOrganism : Bos taurusInfertility and post-partum reproductive diseases present significant clinical and economic challenges, particularly in cattle farming. Successful gestation is largely contingent upon the ability of the maternal immune system to recognize and tolerate the embryo. The role of immune cells in promoting fetal-maternal immune tolerance is critical, underlining their importance in post-partum fertility. In this context, DNA methylation in hematopoietic cells may play a pivotal role in determining the susceptibility of the animal to post-partum fertility problems. Identifying epigenetic changes linked to infertility is therefore crucial for advancing sustainable animal production. Characterizing the methylome of immune cells in relation to fertility will enable early phenotyping, setting the stage for innovative methods to detect potential subfertility in animals. In our study, whole epigenome sequencing and enzymatic methyl-seq (EM-seq) were employed to analyze the DNA methylation patterns in total blood collected from twelve Holstein cows raised on the same farm before any disease appeared. This approach helped to map the epigenetic modification profiles of genes associated with the varying fertility phenotypes observed the following year, revealing significant differences between fertile and subfertile cows. We identified 216,990 differentially methylated cytosines (DMCs), with three genes, Interferon tau-3 (IFNT3), KIAA0825, and RAS-Related Protein 2A (RAP2A), showing high significance. Additionally, 23 key genes affected by DMCs across five regions (transcription start sites-TSS shores, introns, exons, distal intergenic areas, and downstream of genes) were identified. Notably, Interferon tau-3 emerged as especially crucial due to its role in early embryonic development and the establishment of gestation in cattle, with seven DMCs in its TSS shores in subfertile cows. Similarly, the KLRA1 gene (Ly49), analogous to KIRs in humans and primarily expressed on Natural Killer (NK) cells, was highlighted for its potential impact on fertility. Past research underscored that a balance between activating and inhibiting KIR receptors is essential for embryo implantation and proper placental development. Moreover, interleukin genes, such as IL-6, IL15, IL22, IL-36G, which are vital f...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276263" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 140 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä½ çš„çš®è‚¤æœ¬èº«å…·æœ‰æŠ—ç™Œæœºåˆ¶ï¼Œè€Œé˜³å…‰ä¼šå°†å…¶å…³é—­ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šScientists have uncovered how too much sunlight can flip a hidden switch inside skin cells that makes inflammation spiral out of control and increases the risk of cancer. Their research reveals that UV radiation breaks down a protective protein called YTHDF2, which normally prevents a small RNA signal from activating an immune sensor linked to dangerous inflammation. Once that protection is lost, a surprising chain reaction unfolds inside the cell, turning ordinary sun damage into a potential cancer trigger.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251129044505.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>Fructose may quietly supercharge your inflammation</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers found that fructose can prime immune cells to overreact to bacterial toxins. In healthy adults, fructose-sweetened drinks increased receptors that trigger inflammation. This heightened sensitivity may contribute to greater infection risk. The effects could be even more dangerous in people with metabolic diseases.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/11/251129044507.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>RNA-seq</td>
<td>26</td>
</tr>
<tr>
<td>cancer</td>
<td>22</td>
</tr>
<tr>
<td>tumor</td>
<td>11</td>
</tr>
<tr>
<td>transcriptome</td>
<td>10</td>
</tr>
<tr>
<td>scRNA</td>
<td>9</td>
</tr>
<tr>
<td>sequencing</td>
<td>9</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>8</td>
</tr>
<tr>
<td>metabolism</td>
<td>8</td>
</tr>
<tr>
<td>pathway</td>
<td>8</td>
</tr>
<tr>
<td>immune</td>
<td>7</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>6</td>
</tr>
<tr>
<td>T cell</td>
<td>6</td>
</tr>
<tr>
<td>macrophage</td>
<td>6</td>
</tr>
<tr>
<td>methylation</td>
<td>6</td>
</tr>
<tr>
<td>cytokine</td>
<td>6</td>
</tr>
<tr>
<td>metabolic</td>
<td>6</td>
</tr>
<tr>
<td>glioma</td>
<td>5</td>
</tr>
<tr>
<td>inflammation</td>
<td>5</td>
</tr>
<tr>
<td>immunity</td>
<td>5</td>
</tr>
<tr>
<td>RNAseq</td>
<td>5</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (140æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270483" target="_blank" rel="noopener noreferrer">GSE270483 Macrophage Involvement in the Pathology of Chronic Thromboembolic Pulmonary Hypertension: Lessons from Single-Cell and Single-Nucleus RNA Sequencing</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268779" target="_blank" rel="noopener noreferrer">GSE268779 æ¯”è¾ƒç©ºé—´è½¬å½•ç»„å›¾è°±ä¸­æ‰°åŠ¨å“åº”åŒºåŸŸå’ŒåŸºå› çš„é‰´å®š</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE239497" target="_blank" rel="noopener noreferrer">GSE239497 CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310633" target="_blank" rel="noopener noreferrer">GSE310633 OsVAL2 è¿‡è¡¨è¾¾ææ–™çš„åŸå§‹ ChIP-seq æ•°æ®ï¼Œä½¿ç”¨æŠ— FLAG æŠ—ä½“ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275484" target="_blank" rel="noopener noreferrer">GSE275484 äººç±»èƒ¶è´¨ç˜¤ç›¸å…³å·¨å™¬ç»†èƒçš„ä¸€ä¸ªåŠŸèƒ½äºšç¾¤ä¸æ¶æ€§èƒ¶è´¨ç˜¤è¿›å±•ç›¸å…³ - RNA-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275225" target="_blank" rel="noopener noreferrer">GSE275225 ä¸æ¶æ€§èƒ¶è´¨ç˜¤è¿›å±•ç›¸å…³çš„äººç±»èƒ¶è´¨ç˜¤ç›¸å…³å·¨å™¬ç»†èƒçš„åŠŸèƒ½äºšç¾¤ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275224" target="_blank" rel="noopener noreferrer">GSE275224 ä¸æ¶æ€§èƒ¶è´¨ç˜¤è¿›å±•ç›¸å…³çš„äººç±»èƒ¶è´¨ç˜¤ç›¸å…³å·¨å™¬ç»†èƒçš„åŠŸèƒ½äºšç¾¤ [scATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311807" target="_blank" rel="noopener noreferrer">GSE311807 äººç±»å°èƒ¶è´¨ç»†èƒå¯¹ä½“å†…Î²-æ·€ç²‰æ ·è›‹ç™½ã€tauè›‹ç™½å’Œé˜¿å°”èŒ¨æµ·é»˜ç—…ç—…ç†çš„æ··åˆååº”å­˜åœ¨å·®å¼‚[scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311534" target="_blank" rel="noopener noreferrer">GSE311534 Lamin A/C è°ƒèŠ‚è„‚è´¨ä»£è°¢å’Œç‚ç—‡ï¼šæ¥è‡ªå®¶æ—æ€§éƒ¨åˆ†è„‚è‚ªè¥å…»ä¸è‰¯ 2 äºšå‹ 2 æ¨¡å‹çš„å¯ç¤º</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311533" target="_blank" rel="noopener noreferrer">GSE311533 å±‚ç²˜è›‹ç™½A/Cè°ƒèŠ‚è„‚è´¨ä»£è°¢å’Œç‚ç—‡ï¼šæ¥è‡ªå®¶æ—æ€§éƒ¨åˆ†è„‚è‚ªè¥å…»ä¸è‰¯2äºšå‹æ¨¡å‹çš„å¯ç¤º</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311524" target="_blank" rel="noopener noreferrer">GSE311524 è°·æ°¨é…°èƒºé™åˆ¶æ¡ä»¶ä¸‹è½¬å½•ç»„å’Œè›‹ç™½è´¨ç»„ååº”è§£è€¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311344" target="_blank" rel="noopener noreferrer">GSE311344 B16 è‚¿ç˜¤æ¨¡å‹ä¸­ T ç»†èƒçš„ ACT å’Œæ£€æŸ¥ç‚¹é˜»æ–­ - scRNA-seqã€CITE-seq å’Œ TCRab [i35]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311262" target="_blank" rel="noopener noreferrer">GSE311262 åˆ©ç”¨æ‚£è€…æ¥æºçš„å¼‚ç§ç§»æ¤ç»†èƒåœ¨å·¥ç¨‹åŒ–ç»„ç»‡æ¨¡å‹ä¸­é‡ç°æ‚£è€…é—´ç»“ç›´è‚ ç™Œè‚¿ç˜¤å¼‚è´¨æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308942" target="_blank" rel="noopener noreferrer">GSE308942 ErbB3å—ä½“é…ªæ°¨é…¸æ¿€é…¶è°ƒèŠ‚å°è‚ å±éšœåŠŸèƒ½å’Œç´§å¯†è¿æ¥è›‹ç™½Pmp22çš„è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306583" target="_blank" rel="noopener noreferrer">GSE306583 èƒç›˜åˆ«å­•çƒ¯é†‡é…®ä¸è¶³åå°é¼ ä½“æ„Ÿçš®å±‚ã€æµ·é©¬å’Œå°è„‘è½¬å½•ç»„çš„å‘è‚²è½¨è¿¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303697" target="_blank" rel="noopener noreferrer">GSE303697 å•æ ¸ RNA æµ‹åºæ­ç¤ºäº†å…·æœ‰ä¸åŒå…ç–«èƒŒæ™¯çš„å°é¼ ä¾§éš”åŒºç»†èƒå¼‚è´¨æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301537" target="_blank" rel="noopener noreferrer">GSE301537 ç‹¬ç‰¹çš„åºåˆ—ç‰¹å¾å®šä¹‰äº†ç‚ç—‡è®°å¿†çš„è¡¨è§‚é—ä¼ æŒä¹…æ€§ [scATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300583" target="_blank" rel="noopener noreferrer">GSE300583 MOIRA æ˜¯æœè‡æ—¶é’Ÿè›‹ç™½å’ŒåŸºå› èšé›†ä»¥åŠæ­£å¸¸æ˜¼å¤œèŠ‚å¾‹æ‰€å¿…éœ€çš„ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300582" target="_blank" rel="noopener noreferrer">GSE300582 MOIRA æ˜¯æœè‡æ—¶é’Ÿè›‹ç™½å’ŒåŸºå› èšé›†ä»¥åŠæ­£å¸¸æ˜¼å¤œèŠ‚å¾‹æ‰€å¿…éœ€çš„ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289835" target="_blank" rel="noopener noreferrer">GSE289835 ApoE-/- å’Œ Epn1&amp;2-SMCiDKO/ApoE-/- å°é¼  (n=3) ä¸»åŠ¨è„‰çš„å•ç»†èƒ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287445" target="_blank" rel="noopener noreferrer">GSE287445 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [RSK1_KO_RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287444" target="_blank" rel="noopener noreferrer">GSE287444 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [å•æ ¸ç»†èƒæ ¸ç³–ä½“æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287443" target="_blank" rel="noopener noreferrer">GSE287443 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [CRISPR_screen]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287442" target="_blank" rel="noopener noreferrer">GSE287442 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [BMDM_RiboTag-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287441" target="_blank" rel="noopener noreferrer">GSE287441 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [BMDM_Ribo-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287440" target="_blank" rel="noopener noreferrer">GSE287440 å‘ç°ã€é˜æ˜å’Œæ²»ç–—é¶å‘é©±åŠ¨ç»†èƒå› å­é‡Šæ”¾ç»¼åˆå¾çš„è¿‡åº¦ç¿»è¯‘é€šè·¯ [BCAP_KO_BMDM_Ribo-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285986" target="_blank" rel="noopener noreferrer">GSE285986 å¼‚æŸ“è‰²è´¨ä¿çœŸåº¦æ˜¯æ·‹å·´ç˜¤å’Œå…¶ä»–äººç±»ç™Œç—‡çš„æ²»ç–—å¼±ç‚¹ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285592" target="_blank" rel="noopener noreferrer">GSE285592 å¼‚æŸ“è‰²è´¨ä¿çœŸåº¦æ˜¯æ·‹å·´ç˜¤å’Œå…¶ä»–äººç±»ç™Œç—‡çš„æ²»ç–—å¼±ç‚¹[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285575" target="_blank" rel="noopener noreferrer">GSE285575 Syntaxin-6ä»‹å¯¼çš„è‡ªå™¬èµ‹äºˆè‚ç»†èƒç™Œä¹ä¼æ›¿å°¼è€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283882" target="_blank" rel="noopener noreferrer">GSE283882 å•ç»†èƒæµ‹åºæ­ç¤ºå¸çƒŸç›¸å…³æ€§ç‰™å‘¨ç‚ä¸­ä¸Šçš®ç»†èƒä¸ CXCR6+ Treg ç»†èƒçš„ç›¸äº’ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282552" target="_blank" rel="noopener noreferrer">GSE282552 é•¿è¯»é•¿ RNA æµ‹åºæ­ç¤ºç²¾ç¥åˆ†è£‚ç—‡ä¸­å…·æœ‰å·®å¼‚å¼‚æ„ä½“ä½¿ç”¨çš„çªè§¦åŸºå›  [çŸ­è¯»é•¿ RNA æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282551" target="_blank" rel="noopener noreferrer">GSE282551 é•¿è¯»é•¿ RNA æµ‹åºæ­ç¤ºç²¾ç¥åˆ†è£‚ç—‡ä¸­å…·æœ‰å·®å¼‚å¼‚æ„ä½“ä½¿ç”¨çš„çªè§¦åŸºå›  [é•¿è¯»é•¿ RNA æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282171" target="_blank" rel="noopener noreferrer">GSE282171 æŠ‘éƒå’Œç„¦è™‘è¯±å¯¼çš„ä»£è°¢é‡ç¼–ç¨‹é€šè¿‡ CBX5 ä¹³é…¸åŒ–ä¿ƒè¿›è‚ç»†èƒç™Œè¿›å±•ï¼šç‰›ç£ºèƒ†é…¸å’Œ PHGDH ä»‹å¯¼çš„é“æ­»äº¡çš„å‚ä¸</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281469" target="_blank" rel="noopener noreferrer">GSE281469 IKAROSã€HDAC1 å’Œ EZH2 å¯¹ç™½è¡€ç—…ä¸­å¼‚æŸ“è‰²è´¨å½¢æˆå’Œè‚¿ç˜¤æŠ‘åˆ¶çš„è°ƒæ§ [Molt4_CT]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281468" target="_blank" rel="noopener noreferrer">GSE281468 Regulation of heterochromatin formation and tumor suppression in leukemia by IKAROS, HDAC1 and EZH2 [Molt4_RNA]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281327" target="_blank" rel="noopener noreferrer">GSE281327 è‡ªé—­ç—‡è°±ç³»éšœç¢ä¸­çš„æ–°ç”Ÿç»“æ„å˜å¼‚ç ´åç¥ç»å…ƒåŸºå› çš„è¿œç«¯è°ƒæ§ç›¸äº’ä½œç”¨ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281283" target="_blank" rel="noopener noreferrer">GSE281283 è‡ªé—­ç—‡è°±ç³»éšœç¢ä¸­çš„æ–°ç”Ÿç»“æ„å˜å¼‚ç ´åç¥ç»å…ƒåŸºå› çš„è¿œç«¯è°ƒæ§ç›¸äº’ä½œç”¨ [Hi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277238" target="_blank" rel="noopener noreferrer">GSE277238 ICAM1 mRNAé€šè¿‡dsRNA-ILF2/ILF3é€šè·¯æŠ‘åˆ¶è‚ºç™Œä¸­çš„ç¿»è¯‘ï¼Œå…¶åŠŸèƒ½ç‹¬ç«‹äºè›‹ç™½è´¨ç¼–ç ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277143" target="_blank" rel="noopener noreferrer">GSE277143 ç»†èƒå‘¨æœŸé˜»æ»é€šè¿‡å¢å¼ºè‘¡è„ç³–ä»£è°¢å’ŒIL-2ä¿¡å·ä¼ å¯¼æ¥å¢å¼ºCD8+ Tç»†èƒæ•ˆåº”åŠŸèƒ½</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275934" target="_blank" rel="noopener noreferrer">GSE275934 H4K16é…°åŒ–ä¿®é¥°åœ¨ä»£è°¢æ‰°åŠ¨æœŸé—´å¾®è°ƒè½¬å½•ååº”ï¼ˆRNA-seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275933" target="_blank" rel="noopener noreferrer">GSE275933 H4K16é…°åŒ–ä¿®é¥°åœ¨ä»£è°¢æ‰°åŠ¨æœŸé—´å¾®è°ƒè½¬å½•ååº”ï¼ˆChIP-seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275932" target="_blank" rel="noopener noreferrer">GSE275932 H4K16é…°åŒ–åœ¨ä»£è°¢æ‰°åŠ¨æœŸé—´å¾®è°ƒè½¬å½•ååº”ï¼ˆATAC-seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274750" target="_blank" rel="noopener noreferrer">GSE274750 PMEPA1çš„è‡´ç™Œä½œç”¨åŠå…¶ä¸è‚ç»†èƒç™Œä¸­å…ç–«è€—ç«­å’ŒTGF-Î²æ¿€æ´»çš„å…³ç³»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271675" target="_blank" rel="noopener noreferrer">GSE271675 å‰åˆ—è…ºç™Œä»åŸå‘åˆ°è½¬ç§»æ‰©æ•£çš„è‚¿ç˜¤å¼‚è´¨æ€§åŠ¨æ€å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271622" target="_blank" rel="noopener noreferrer">GSE271622 è‚ ç¥ç»å…ƒä¸¢å¤±å¯¹è‚ é“ç»†èƒç»„æˆçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268561" target="_blank" rel="noopener noreferrer">GSE268561 ç ”ç©¶å‘ç°ï¼Œå‘è‚²æœŸæš´éœ²äºç”²é…¯ç£ºé…¸ç›å¯é€šè¿‡æ‰°ä¹± Notch/Hes ä¿¡å·é€šè·¯ï¼Œç ´åç¥ç»å…ƒåˆ†åŒ–ï¼Œä»è€Œè¯±å¯¼å°é¼ å‡ºç°ç±»ä¼¼è‡ªé—­ç—‡çš„è¡Œä¸ºç¼ºé™·ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266425" target="_blank" rel="noopener noreferrer">GSE266425 ç£·é…¸åŒ– RB æŠ‘åˆ¶ ETS1 çš„è½¬å½•æ´»æ€§ï¼Œä»è€Œè°ƒèŠ‚å‰åˆ—è…ºç™Œç»†èƒå¯¹ CDK4/6 æŠ‘åˆ¶å‰‚çš„æ•æ„Ÿæ€§ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259251" target="_blank" rel="noopener noreferrer">GSE259251 ndufs2-/-æ–‘é©¬é±¼æ¨¡å‹è¡¨ç°å‡ºè±æ°ç»¼åˆå¾çš„ç‰¹å¾ï¼ŒåŒ…æ‹¬å¯¿å‘½ç¼©çŸ­ã€å‘è‚²å¼‚å¸¸ã€è½¬å½•ç»„æ”¹å˜å’Œä»£è°¢ç´Šä¹±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249943" target="_blank" rel="noopener noreferrer">GSE249943 ä¹³è…ºç™Œç»†èƒèƒ½å¤Ÿè¯†åˆ«å¹¶å“åº”ä¸åŒæ°´å¹³çš„å­•æ¿€ç´ ï¼Œä»è€Œäº§ç”Ÿä¸åŒçš„è¡¨å‹è¾“å‡º [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249939" target="_blank" rel="noopener noreferrer">GSE249939 ä¹³è…ºç™Œç»†èƒèƒ½å¤Ÿè¯†åˆ«å¹¶å“åº”ä¸åŒæ°´å¹³çš„å­•æ¿€ç´ ï¼Œä»è€Œäº§ç”Ÿä¸åŒçš„è¡¨å‹è¾“å‡º [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE239353" target="_blank" rel="noopener noreferrer">GSE239353 CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE223746" target="_blank" rel="noopener noreferrer">GSE223746 Single-cell Transcriptome Atlas of the uroclepsia Rat urethra with LIPUS treatment</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE185914" target="_blank" rel="noopener noreferrer">GSE185914 Integrating multi-omics data with genome scale metabolic modeling for the analysis of Pseudomonas aeruginosa persister cells</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138321" target="_blank" rel="noopener noreferrer">GSE138321 Microbial activation of intestinal TLRs is critical for the establishment of normal behavior</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271330" target="_blank" rel="noopener noreferrer">GSE271330 CBLL1 (HAKAI) RNAç”²åŸºè½¬ç§»é…¶å¤åˆç‰©ç»„åˆ†åœ¨ä¹³è…ºç™Œç»†èƒï¼ˆMDA-MB-231ï¼‰é›„æ¿€ç´ ä¿¡å·ä¼ å¯¼ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271326" target="_blank" rel="noopener noreferrer">GSE271326 CBLL1 (HAKAI) RNAç”²åŸºè½¬ç§»é…¶å¤åˆç‰©æˆåˆ†åœ¨ä¹³è…ºç™Œç»†èƒ (MCF-7) åŸºç¡€ä¿¡å·ä¼ å¯¼å’Œé›Œæ¿€ç´ ä¿¡å·ä¼ å¯¼ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE234571" target="_blank" rel="noopener noreferrer">GSE234571 METTL3:METTL14 RNAç”²åŸºè½¬ç§»é…¶è°ƒæ§MDA-MB-231ä¹³è…ºç™Œç»†èƒä¸­çš„åŸºå› è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE234322" target="_blank" rel="noopener noreferrer">GSE234322 METTL3 RNAç”²åŸºè½¬ç§»é…¶æŠ‘åˆ¶å¯¹ä¹³è…ºç™Œç»†èƒåŸºå› è¡¨è¾¾çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195532" target="_blank" rel="noopener noreferrer">GSE195532 METTL3 RNAç”²åŸºè½¬ç§»é…¶è°ƒæ§MCF-7ä¹³è…ºç™Œç»†èƒä¸­çš„é›Œæ¿€ç´ ä¿¡å·ä¼ å¯¼</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE195487" target="_blank" rel="noopener noreferrer">GSE195487 RNAç”²åŸºè½¬ç§»é…¶å¤åˆç‰©çš„METTL14ç»„åˆ†å½±å“MCF-7ä¹³è…ºç™Œç»†èƒä¸­çš„é›Œæ¿€ç´ ä¿¡å·ä¼ å¯¼</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284223" target="_blank" rel="noopener noreferrer">GSE284223 è¡¨çš®ç‰¹å¼‚æ€§ Nampt cKO å°é¼ çš®è‚¤çš„ç»¼åˆè½¬å½•ç»„åˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310631" target="_blank" rel="noopener noreferrer">GSE310631 æ°´ç¨»åŸºå›  OsVAL2 è¿‡è¡¨è¾¾å’Œæ•²é™¤çªå˜æ ªç³»çš„åŸå§‹ RNA-seq æ•°æ®ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310630" target="_blank" rel="noopener noreferrer">GSE310630 æ°´ç¨»åŸºå›  OsDOF3 çš„é‡ç”Ÿå‹å’Œè¿‡è¡¨è¾¾æ ªç³»çš„åŸå§‹ RNA-seq æ•°æ®ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272216" target="_blank" rel="noopener noreferrer">GSE272216 äººç±»èƒ¶è´¨ç˜¤ç›¸å…³å·¨å™¬ç»†èƒçš„ä¸€ä¸ªåŠŸèƒ½äºšç¾¤ä¸æ¶æ€§èƒ¶è´¨ç˜¤è¿›å±•ç›¸å…³</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311743" target="_blank" rel="noopener noreferrer">GSE311743 Modeling Liver Cancer Molecular and Histological Features by CRISPR Editing of Primary Porcine Hepatocytes</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311543" target="_blank" rel="noopener noreferrer">GSE311543 Trithorax é€šè¿‡ Ptx1 ä»‹å¯¼çš„ EE ç‰¹åŒ–æŠ‘åˆ¶æ¥å¹³è¡¡ ISC å‘½è¿å†³å®š [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311542" target="_blank" rel="noopener noreferrer">GSE311542 Trithorax é€šè¿‡ Ptx1 ä»‹å¯¼çš„ EE ç‰¹åŒ–æŠ‘åˆ¶æ¥å¹³è¡¡ ISC å‘½è¿å†³å®š [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311496" target="_blank" rel="noopener noreferrer">GSE311496 ç ”ç©¶å¹²ç‡¥ç»¼åˆå¾å’Œéå¹²ç‡¥ç»¼åˆå¾ç›¸å…³å¹²çœ¼ç—‡çš„ç»“è†œå…ç–«é€šè·¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311255" target="_blank" rel="noopener noreferrer">GSE311255 ç”¨äºç”Ÿç‰©ç›‘æµ‹å’Œæœºåˆ¶ç ”ç©¶çš„RNAç±»åˆ«å¤æ‚è½¬å½•ç»„å­¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311144" target="_blank" rel="noopener noreferrer">GSE311144 é€šè¿‡åŒParABSåˆ†åŒºç³»ç»Ÿç¨³å®šé—ä¼ é“¾éœ‰èŒçº¿æ€§è´¨ç²’SCP1 [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311079" target="_blank" rel="noopener noreferrer">GSE311079ï¼šç”¨CM-PEG-PLGA@DOX/R848çº³ç±³é¢—ç²’å¤„ç†RAW264.7ç»†èƒä¸PBSå¯¹ç…§ç»„çš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311078" target="_blank" rel="noopener noreferrer">GSE311078ï¼šCM-PEG-PLGA@DOX/R848çº³ç±³é¢—ç²’å¤„ç†4T1ç»†èƒä¸PBSå¯¹ç…§ç»„çš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311038" target="_blank" rel="noopener noreferrer">GSE311038 å¤åˆ¶æ€§è¡°è€æ¨¡å‹ä¸­è¡°è€å†…çš®ç»†èƒåŠå…¶è¡ç”Ÿç»†èƒå¤–å›Šæ³¡çš„å¤šç»„å­¦æ•´åˆæ–¹æ³• [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310979" target="_blank" rel="noopener noreferrer">GSE310979 å¶é…¸ç»“åˆè›‹ç™½è¯±å¯¼KBç™Œç»†èƒæ¯’æ€§çš„ä¿¡å·ä¼ å¯¼å’Œæœºåˆ¶ç ”ç©¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310845" target="_blank" rel="noopener noreferrer">GSE310845 è‚ é“å¹²ç»†èƒå’Œç¥–ç»†èƒåœ¨ç‚ç—‡æ€§è‚ ç—…ä¸­å¯¹ç‚ç—‡åº”æ¿€è¡¨ç°å‡ºä¸åŒçš„é€‚åº”æ€§ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310735" target="_blank" rel="noopener noreferrer">GSE310735 YBX1 è°ƒèŠ‚ç»†èƒç¨³æ€ä»¥é¢„é˜²ç‚ç—‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310703" target="_blank" rel="noopener noreferrer">GSE310703 äººç±»æˆçº¤ç»´ç»†èƒ MRC5 ç»†èƒåœ¨ RAF ç™ŒåŸºå› æ¿€æ´»åçš„åŸºå› è¡¨è¾¾è°±åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310275" target="_blank" rel="noopener noreferrer">GSE310275 è½¬å½•å› å­ OsWRKY36 é€šè¿‡è°ƒèŠ‚æ²¹èœç´ ç”¾é†‡ä¿¡å·ä¼ å¯¼æ¥è°ƒæ§æ°´ç¨»å¶ç‰‡å…³èŠ‚å‘è‚²å’Œå¶ç‰‡è§’åº¦ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310085" target="_blank" rel="noopener noreferrer">GSE310085 èåœç¡«ç´ é€šè¿‡æŠ‘åˆ¶PI3K/AKT/mTORå’ŒHIF-1Î±é€šè·¯æŠ‘åˆ¶ç»“ç›´è‚ ç™Œè¿›å±•ï¼Œä¸”åœ¨ç¼ºæ°§æ¡ä»¶ä¸‹ç–—æ•ˆå¢å¼º</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307273" target="_blank" rel="noopener noreferrer">GSE307273 å¹´é¾„ç›¸å…³çš„ G-å››é“¾ä½“ç§¯ç´¯å’Œ DDX5 ä¸¢å¤±å¡‘é€ äººç±»æ˜Ÿå½¢èƒ¶è´¨ç»†èƒçš„æŸ“è‰²è´¨æ™¯è§‚ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307272" target="_blank" rel="noopener noreferrer">GSE307272 å¹´é¾„ç›¸å…³çš„ G-å››é“¾ä½“ç§¯ç´¯å’Œ DDX5 ä¸¢å¤±å¡‘é€ äººç±»æ˜Ÿå½¢èƒ¶è´¨ç»†èƒçš„æŸ“è‰²è´¨æ™¯è§‚ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306951" target="_blank" rel="noopener noreferrer">GSE306951 åˆ©ç”¨èœ‚èƒ¶æå–ç‰©å¯¹ç»¿è‰²åˆæˆæ°§åŒ–é”Œçº³ç±³é¢—ç²’è¯±å¯¼æ–‘é©¬é±¼å…ç–«ååº”è¿›è¡Œè½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306591" target="_blank" rel="noopener noreferrer">GSE306591 æŸ“è‰²è´¨ç»“åˆçš„ Mtf2 é™åˆ¶åŸå§‹å¤šèƒ½æ€§ä¸­çš„èƒšå¤–å‘è‚²èƒ½åŠ› [scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306510" target="_blank" rel="noopener noreferrer">GSE306510 SPP1+å·¨å™¬ç»†èƒä¿ƒè¿›æ¥è§¦æ€§è¿‡æ•ä¸­çš„æ¯›å‘ç”Ÿé•¿[scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306509" target="_blank" rel="noopener noreferrer">GSE306509 SPP1+å·¨å™¬ç»†èƒä¿ƒè¿›æ¥è§¦æ€§è¶…æ•ååº”ä¸­çš„æ¯›å‘ç”Ÿé•¿[æ‰¹é‡RNAæµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305449" target="_blank" rel="noopener noreferrer">GSE305449 å°é¼ èƒ°è…ºÎ±è°±ç³»ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303631" target="_blank" rel="noopener noreferrer">GSE303631 CDCP1 å’Œå¿ƒè‚Œçº¤ç»´åŒ–åœ¨æ‰©å¼ å‹å¿ƒè‚Œç—… (DCM) å°é¼ æ¨¡å‹ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302326" target="_blank" rel="noopener noreferrer">GSE302326 å®¿ä¸»-ç—…åŸä½“ç›¸äº’ä½œç”¨æœŸé—´çš„ç»„è›‹ç™½ä¹³é…¸åŒ–ï¼šé“œç»¿å‡å•èƒèŒç¾¤ä½“æ„Ÿåº”ä¿¡å·ä¸å®¿ä¸»ä¹³é…¸ä¹‹é—´çš„å¯†åˆ‡å’ŒæŒç»­å…³ç³» [CUT&amp;RUN]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302311" target="_blank" rel="noopener noreferrer">GSE302311 å®¿ä¸»-ç—…åŸä½“ç›¸äº’ä½œç”¨è¿‡ç¨‹ä¸­çš„ç»„è›‹ç™½ä¹³é…¸åŒ–ï¼šé“œç»¿å‡å•èƒèŒç¾¤ä½“æ„Ÿåº”ä¿¡å·ä¸å®¿ä¸»ä¹³é…¸ä¹‹é—´å¯†åˆ‡è€ŒæŒä¹…çš„å…³ç³»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301850" target="_blank" rel="noopener noreferrer">GSE301850 è¡¨çš®ç»†èƒèåˆä¿ƒè¿›ç§€ä¸½éšæ†çº¿è™«ä»èƒšèƒè½¬å½•ç»„å‘å¹¼è™«è½¬å½•ç»„çš„è½¬å˜</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300516" target="_blank" rel="noopener noreferrer">GSE300516 è„‘ç¼ºè¡€å°é¼ æ¨¡å‹ä¸­5-ç”²åŸºèƒå˜§å•¶ä¿®é¥°å’Œè¡¨è¾¾è°±çš„è½¬å½•ç»„èŒƒå›´åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300050" target="_blank" rel="noopener noreferrer">GSE300050 ç‹¬ç‰¹çš„åºåˆ—ç‰¹å¾å®šä¹‰äº†ç‚ç—‡è®°å¿†çš„è¡¨è§‚é—ä¼ æŒä¹…æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299343" target="_blank" rel="noopener noreferrer">GSE299343 æ‰¹é‡ RNA æµ‹åº S64F MAFA é›„æ€§èƒ°å²›</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295793" target="_blank" rel="noopener noreferrer">GSE295793 ç ”ç©¶æ›¿ä»£ç”œå‘³å‰‚å¯¹ä¹³é…¸æ†èŒç”Ÿé•¿å’Œä»£è°¢çš„å½±å“åŠå…¶å¯¹é£Ÿæºæ€§ç—…åŸä½“çš„æ€èŒæœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294870" target="_blank" rel="noopener noreferrer">GSE294870 Tauè›‹ç™½é€šè¿‡å¢å¼ºè„‚è‚ªé…¸Î²-æ°§åŒ–è¯±å¯¼çš„ç»†èƒè¡°è€æ¥æŠ‘åˆ¶èƒ¶è´¨ç˜¤è¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289914" target="_blank" rel="noopener noreferrer">GSE289914 ä¸€ç§æ–°å‹é£Ÿå“å¯æ¢å¤è¥¿æ–¹é¥®é£Ÿè¯±å¯¼çš„MASLDå°é¼ çš„å¼‚å¸¸DNAç”²åŸºåŒ–æ¨¡å¼</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289250" target="_blank" rel="noopener noreferrer">GSE289250 èŠè¯é…šé€šè¿‡æŠ‘åˆ¶è§’è´¨å½¢æˆç»†èƒçš„ TRPV3/NF-ÎºB/CCL3 è½´ç¼“è§£ç‰¹åº”æ€§çš®ç‚çš„çš®è‚¤ç‚ç—‡å’Œç˜™ç—’</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287309" target="_blank" rel="noopener noreferrer">GSE287309 å°é¼ å°‘çªèƒ¶è´¨ç»†èƒSerpina3nç¼ºå¤±å¯¹è„‘è¡°è€çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286298" target="_blank" rel="noopener noreferrer">GSE286298 å¼‚æŸ“è‰²è´¨ä¿çœŸåº¦æ˜¯æ·‹å·´ç˜¤å’Œå…¶ä»–äººç±»ç™Œç—‡çš„æ²»ç–—å¼±ç‚¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285894" target="_blank" rel="noopener noreferrer">GSE285894 æ–°ç”ŸRNA m6Aä¿®é¥°å‚ä¸CRPC-V16Aç¼ºæ°§æ¡ä»¶ä¸‹Tç»†èƒæ´»åŒ–åŸºå› ç‰¹å¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285442" target="_blank" rel="noopener noreferrer">GSE285442 HUä¹™é…°åŒ–é€šè¿‡HDAHä»‹å¯¼å¯¹å¤§è‚ æ†èŒä»£è°¢è¿›è¡Œæ­£åé¦ˆè°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285168" target="_blank" rel="noopener noreferrer">GSE285168 TBX5 å‰‚é‡é™ä½é€šè¿‡ç ´åå¿ƒæˆ¿å¿ƒè‚Œç»†èƒèº«ä»½çš„å‘è‚²åŸºå› è°ƒæ§å¯¼è‡´äººç±»å¿ƒæˆ¿ç–¾ç—… [scATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284720" target="_blank" rel="noopener noreferrer">GSE284720 RNA-seq åˆ†ææ­ç¤ºäº†ç»†é¢—ç²’ç‰© (PM2.5) ä¸­ä¸åŒæœ‰æœºæˆåˆ†å¯¹äººç±»é¼»æˆçº¤ç»´ç»†èƒçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284078" target="_blank" rel="noopener noreferrer">GSE284078 RNA-Seq åˆ†æäº†ç”¨ SGLT2 æŠ‘åˆ¶å‰‚è¾¾æ ¼åˆ—å‡€æ²»ç–—çš„ Akita å°é¼ å’Œé‡ç”Ÿå‹å¯¹ç…§å°é¼ çš„èƒ°å²›ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279446" target="_blank" rel="noopener noreferrer">GSE279446 å•ä¸ª microRNA é¶æ ‡çš„å»æŠ‘åˆ¶å¯¼è‡´å°é¼ é›Œæ€§ä¸å­• [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE276336" target="_blank" rel="noopener noreferrer">GSE276336 ZEB1ä»‹å¯¼çš„ç»“ç›´è‚ ç™ŒHT-29ç»†èƒç³»ä¸Šçš®é—´è´¨è½¬åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274447" target="_blank" rel="noopener noreferrer">GSE274447 å°é¼ è„‘å†…ä½“å†…ç©ºé—´æ‰°åŠ¨åºåˆ—</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274244" target="_blank" rel="noopener noreferrer">GSE274244 Arx åœ¨å‘è‚²ä¸­çš„ä¸­é—´ç¥ç»å…ƒä¸­çš„ä½œç”¨ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274243" target="_blank" rel="noopener noreferrer">GSE274243 Arx åœ¨å‘è‚²ä¸­çš„ä¸­é—´ç¥ç»å…ƒä¸­çš„ä½œç”¨ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273445" target="_blank" rel="noopener noreferrer">GSE273445 æ¯’è•ˆç¢±æ¿€åŠ¨å‰‚é€šè¿‡é’™-ATPä»£è°¢è½´æ¢å¤é€€åŒ–çš„å”¾æ¶²è…º[snRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272876" target="_blank" rel="noopener noreferrer">GSE272876 åˆ©ç”¨çº³ç±³å­” tRNA æµ‹åºå¯¹ 43 ç§ä¸åŒçš„ RNA ä¿®é¥°è¿›è¡Œæ¯”è¾ƒåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272422" target="_blank" rel="noopener noreferrer">GSE272422 Sirt5 é€šè¿‡è›‹ç™½è´¨èµ–æ°¨é…¸ä¸™äºŒé…°åŒ–è°ƒæ§è½¯éª¨ç»†èƒä»£è°¢å’Œéª¨å…³èŠ‚ç‚å‘å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271303" target="_blank" rel="noopener noreferrer">GSE271303 å¡æ³¢è¥¿æ–¯è‚‰ç˜¤é˜Ÿåˆ—çš„æ•´åˆåŠŸèƒ½åŸºå› ç»„å­¦åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266938" target="_blank" rel="noopener noreferrer">GSE266938 æˆå¹´è‚è„è‚ç»†èƒä¸­ SWI/SNF ATPase æ´»æ€§çš„ç¼ºå¤±ä¼šç ´åæ˜¼å¤œèŠ‚å¾‹åŸºå› è¡¨è¾¾å’Œè‚è„ä¸­æ¢åŠŸèƒ½ [RNAseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266426" target="_blank" rel="noopener noreferrer">GSE266426 ç£·é…¸åŒ– RB æŠ‘åˆ¶ ETS1 çš„è½¬å½•æ´»æ€§ï¼Œä»è€Œè°ƒèŠ‚å‰åˆ—è…ºç™Œç»†èƒå¯¹ CDK4/6 æŠ‘åˆ¶å‰‚çš„æ•æ„Ÿæ€§ [CUT&amp;Tag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261053" target="_blank" rel="noopener noreferrer">GSE261053 RNAPII ç»•è¿‡é˜»æ–­æŸä¼¤æ­ç¤º DNA æŸä¼¤æŠµæŠ—çš„å…³é”®è§è§£ [PRO-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260852" target="_blank" rel="noopener noreferrer">GSE260852 é»è¿è›‹ç™½åè°ƒ RNA èšåˆé…¶ II è½¬å½•çš„å¤šæ­¥éª¤è¿‡ç¨‹ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252312" target="_blank" rel="noopener noreferrer">GSE252312 åŸºäºåŒ–å­¦åˆ†å­ç­›é€‰çš„å¤©ç„¶äººç±»èƒšèƒå¹²ç»†èƒæ–°å‹åŸ¹å…»ç³»ç»Ÿ[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252086" target="_blank" rel="noopener noreferrer">GSE252086 å¿ƒè‚Œæ¢—æ­»åå•æ ¸ç»†èƒå‘½è¿å†³å®šçš„é—ä¼ å®šä½</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250411" target="_blank" rel="noopener noreferrer">GSE250411 å¼‚äº®æ°¨é…°-tRNAåˆæˆé…¶1æ–°çªå˜é€šè¿‡ç¨³å®šç»„ç»‡è›‹ç™½é…¶Zä¿ƒè¿›è‚ºè¡¨é¢æ´»æ€§ç‰©è´¨çš„æ²‰ç§¯[scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250270" target="_blank" rel="noopener noreferrer">GSE250270 å¼‚äº®æ°¨é…°-tRNA åˆæˆé…¶ 1 çš„æ–°çªå˜é€šè¿‡ç¨³å®šç»„ç»‡è›‹ç™½é…¶ Z ä¿ƒè¿›è‚ºè¡¨é¢æ´»æ€§ç‰©è´¨çš„æ²‰ç§¯ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE250140" target="_blank" rel="noopener noreferrer">GSE250140 è‚ºç»†èƒç‰¹å¼‚æ€§é©±åŠ¨å› å­å¯¹ç¿»è¯‘æ ¸ç³–ä½“äº²å’Œçº¯åŒ–-RNAæµ‹åº (TRAPseq) çš„æ¯”è¾ƒç ”ç©¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249945" target="_blank" rel="noopener noreferrer">GSE249945 ä¹³è…ºç™Œç»†èƒèƒ½å¤Ÿè¯†åˆ«å¹¶å“åº”ä¸åŒæ°´å¹³çš„å­•æ¿€ç´ ï¼Œä»è€Œäº§ç”Ÿä¸åŒçš„è¡¨å‹ç»“æœ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247828" target="_blank" rel="noopener noreferrer">GSE247828 Bulk RNA-seq analysis of nilotinib resistant JURL-MK1 cells compared against parental JURL-MK1 cells.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247827" target="_blank" rel="noopener noreferrer">GSE247827 Single cell RNA-seq analysis of the effects of fluphenazine and/or nilotinib on primary CML CD34+CD38- cells</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247826" target="_blank" rel="noopener noreferrer">GSE247826 Bulk RNA-seq analysis for knockdowns of dopamine receptors DRD3 or DRD4 in JURL-MK1 cells +/- TKI (nilotinib) in vitro.</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE242511" target="_blank" rel="noopener noreferrer">GSE242511 Reciprocal inflammatory signals establish profibrotic cross-feeding metabolism [young_old_bleo]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE237235" target="_blank" rel="noopener noreferrer">GSE237235 Integrative genome-wide analysis reveals the RNA-binding motifs of yeast Pcf11 and its role in fine-tuning terminator strength</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224011" target="_blank" rel="noopener noreferrer">GSE224011 Fc glyco-engineered PD-L1 antibody harnesses Fcg Receptors for increased antitumor efficacy</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE221069" target="_blank" rel="noopener noreferrer">GSE221069 Effects of gestational exposure to air pollution on placental methylation mark</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE220648" target="_blank" rel="noopener noreferrer">GSE220648 Nascent RNA-seq from in-vitro stimulated WT and Il2ra-deficient CD8 T cells</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE207991" target="_blank" rel="noopener noreferrer">GSE207991 High-throughput single cell RNA-sequencing of developing lens for cataract gene discovery</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE203198" target="_blank" rel="noopener noreferrer">GSE203198 Integrated control of mitochondrial dynamics and cancer cell stemness by Ïƒ1 receptor</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196382" target="_blank" rel="noopener noreferrer">GSE196382 Defining transcripts regulated by RBBP4/p300 complex in glioblastoma [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196381" target="_blank" rel="noopener noreferrer">GSE196381 Mapping chromatin landscape regulated by RBBP4/p300 complex in glioblastoma  [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189447" target="_blank" rel="noopener noreferrer">GSE189447 RNA sequencing of glk1 glk2 double mutants  under LD conditions at ZT16</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE175810" target="_blank" rel="noopener noreferrer">GSE175810 An ancestral inductive program endows neural crest cells with skeletogenic potential [scATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE168398" target="_blank" rel="noopener noreferrer">GSE168398 De novo methylation enforces long-term lineage-specific programing of TFH and TH1 memory cells [WGBS]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160065" target="_blank" rel="noopener noreferrer">GSE160065 A facile dCAS9-M. EcoGII system for targeted DNA 6mA methylation in living cell</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE108449" target="_blank" rel="noopener noreferrer">GSE108449 Altas of gene expression in mice liver during liver regeneration process post 2/3 partial hepatectomy using RNA-seq</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-01 21:32</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>